2022. TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. 9, 3 (Apr. 2022), 92–101. DOI:https://doi.org/10.53366/jimki.v9i3.488.